select between over 22,900 AI Tool and 17,900 AI News Posts.
German biotech startup Ovo Labs has developed new technologies to “rejuvenate” human eggs, potentially boosting the chances of conception. The therapeutics are designed to enhance in vitro fertilisation (IVF), one of the most transformative advances in reproductive medicine. The first baby was born via IVF more than 40 years ago. Since then, the technology has helped millions of women get pregnant. However, IVF can put significant emotional, psychological, and financial strain on patients. It is often unsuccessful on the first attempt. Some try multiple times without success. For many, IVF ultimately does not lead to parenthood. Ovo Labs wants to…This story continues at The Next Web
<p>Despite growing chatter about a future when much human work is automated by AI, one of the ironies of this current tech boom is how stubbornly reliant on human beings it remains, specifically [...]